Display Settings:

Format

Send to:

Choose Destination
    Crit Care. 2005 Apr;9(2):149-50. Epub 2005 Feb 28.

    Blood flow, not hypoxia, determines intramucosal PCO2.

    Source

    Pulmonary and Critical Care Medicine Division, Department of Medicine, The George Washington University Medical Center, Washington, DC, USA. ggutierrez@mfa.gwu.edu

    Abstract

    Monitoring tissue hypoxia in critically ill patients is a challenging task. Tissue PCO2 has long been proposed as a marker of tissue hypoxia, although there is considerable controversy on whether the rise in CO2 with hypoxia is caused by anaerobic metabolism and excess CO2 production or by the accumulation of aerobically produced CO2 in the setting of blood flow stagnation. The prevention of increases in intestinal PCO2 in aggressively resuscitated septic animals supports the notion that tissue CO2 accumulation is a function of decreases in blood flow, not of tissue hypoxia.

    PMID:
    15774068
    [PubMed - indexed for MEDLINE]
    PMCID: PMC1175940
    Free PMC Article

      Supplemental Content

      Click here to read

      Chemical compound information

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk